Zhejiang Tailin Bioengineering Co Ltd. Stock Analysis 300813.SZ

Zhejiang Tailin Bioengineering Co., Ltd. engages in the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products, as well as organic substance analysis instruments. The company is headquartered in Hangzhou, Zhejiang and currently employs 790 full-time employees. The company went IPO on 2020-01-14. The firm's microbial detection technology product series includes bacteria collectors, bacteria collectors, microbial testers and others. The firm's aseptic production and contamination control equipment series includes isolators, aseptic transfer chambers and containment isolators and others. The firm's organic monitoring and analysis instrument series includes solid combustion devices, biodegradation test systems and headspace oxygen analyzers and others. The firm's products are used in industries such as biopharmaceuticals, medical and health care, experimental animal research, food safety, water quality monitoring and environmental protection.